share_log

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target

HC Wainwright & Co.重申买入Spero Therapeutics,维持7美元的目标价
Benzinga ·  2023/11/14 06:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 price target.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱重申Spero Therapeutics(纳斯达克股票代码:SPRO)买入并维持7美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发